TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
MNKD

MannKind Corp

Healthcare · Biotechnology

3.50$ -1.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement MNKD
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-93.3% +137.2% +126.3% +3.3% +15.8% +32.2% +99.4% +43.5% +22.2%
-17.3% -64.3% -65.6% +18.9% +36.6% -11.9% +57.7% +48.0% +9.2% +22.0% -20.2%
-104.4% +375.1% +15.5% -9.7% +15.5% +222.2% +53.4% +37.8%
-70.4% -49.7% -5.4% -38.1% -21.0% -9.4% +97.1% +60.2% +58.6% +46.7% +44.6%
+36.6% -75.0% +176.9% +6.3% -6.3% -69.4% +39.4% +18.3% +12.8% +121.8% +52.8%
+13.7% -70.8% +49.1% -0.5% -9.9% +11.0% -5.4% +27.2% +19.9% +6.9% +82.7%
-260.9% +736.4% -46.5%
+18.0% -23.4% -28.1% -28.9% +15.5% -13.2% +75.0% +49.4% +1.6% +51.0% -63.6%
-193.3% -95.4%
+244.4% +12.3% -99.6% +370.6% +3,160.8% -102.8% +128.0% -93.7% +87.7% -252.1%
-193.4% -78.7%
-258.3% +412.0% -64.5%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?